Pharmaceutical Industry
Page 15 of 100
SuccessMajor investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
By Ryan HoggApril 10, 2024
By Carla K. Johnson and The Associated PressApril 8, 2024
By Matthew Perrone and The Associated PressApril 4, 2024
By John KellApril 3, 2024
Health‘This is an emergency’: Trade group warns nearly a third of all independent pharmacies will go extinct because of a CMS rule
By Maia Anderson, Healthcare Brew and Morning BrewMarch 30, 2024
RetailWalgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says
By Sasha RogelbergMarch 29, 2024
CommentaryThe economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives
By Howard DeanMarch 28, 2024
HealthOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By Madison Muller, Robert Langreth and BloombergMarch 28, 2024
LeadershipChina woos CEOs of Apple, chipmakers, pharma giants as geopolitical tensions mount: ‘The risk-reward has changed’
By BloombergMarch 23, 2024
CommentaryBayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
By Bill AndersonMarch 21, 2024
By Lindsey LeakeMarch 18, 2024
By Diane BradyMarch 14, 2024
Most Popular
